Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/20/24 06:10 | 6/18/24 | VXRT | Health | BioPrd | Biological Products, (No Diag | Watson W. Mark | CA | D | P | 14 | 0.6789 | 0 | 20 | 34 | 78 | D | |||||||||||||||
12/28/22 17:25 | 12/28/22 | VXRT | Health | BioPrd | Biological Products, (No Diag | Watson W. Mark | CA | D | P | 15 | 0.7570 | 0 | 20 | New | 20 | D | |||||||||||||||
6/23/22 16:32 | 6/22/22 | VXRT | Health | BioPrd | Biological Products, (No Diag | Ahmad Fuad | CA | O | Interim | P | 16 | 3.22 | 0 | 5 | New | 5 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |